Ciamexone as a selective immunosuppressant

Details Ciamexone as a selective immunosuppressant Ciamexone as a selective immunosuppressant

1988-05-25

1991-10-08

Draper, Garnette D.

Drug, bio-affecting and body treating compositions

Lymphokine

424 88, 514340, 514825, 514866, 514903, A61K 3900

Patent

active

050552902

ABSTRACT:
A method of selectively suppressing the excess immune reaction produced iatrogenically or autochthonously by administering 0.1 to 100 mg of ciamexone per kg of body weight.

REFERENCES:
Fahey et al., Annal of Internal Medicine, 106, 1987, pp. 257-274.
Filipovich et al., Immunology Today, vol. 4(2), 1983.
Immunology, ed Roitt, 1985, pp. 23.2-23.3.
Bicker, Chapter 21 g, Immune, Modulation Agents and Their Mechanism, ed. Fenichel et al., 1984, pp. 447-473.
Bicker et al., "Journal of Immunopharmacoloty", 7(1): 127-139 (1985).
Katz, "The Immune System: An Overview", pp. 13-20.
Cooper et al., "B Lymphocytes", pp. 43-55.
Webb et al., "Immunosuppression, Immunopotentiation, & Anti-Inflammatory Drugs", pp. 277-292.
Roitt, "Immunology", 23.11 & 8.3.
Stites et al., "Basic & Clinical Immunology", pp. 430-459.
Rothfield, "The Journal of Clinical Investigation", vol. 46, No. 11 (1967).
"Bulletin on the Rheumatic Diseases", vol. 24, pp. 756-761.
Abruzzo et al., "IgG Anti-IgG Antibodies in Rheumatoid Arthritis and Certain Other Conditions", pp. 258-261.

Affiliated with

Also associated with

Rating

Ciamexone as a selective immunosuppressant does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ciamexone as a selective immunosuppressant, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ciamexone as a selective immunosuppressant will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-255999